SCHEMBL13636679

SCHEMBL13636679

CC1CCCC2C1CCCC21OCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12522502 0.71 POLB (0.30)
SCHEMBL24413401 0.71 MAPT (0.30)
SCHEMBL22614876 0.69 ALDH1A1 (0.39)
SCHEMBL2353431 0.69 ALDH1A1 (0.39)
SCHEMBL14438964 0.69
SCHEMBL10516694 0.66
SCHEMBL13390428 0.66
SCHEMBL10020900 0.65
SCHEMBL11003257 0.64 HSD17B10 (0.31)
SCHEMBL18886008 0.64 CA1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1591437-B1 Interleukin-1 and tumor necrosis factor-alpha modulators, syntheses of said modulators and methods of using said modulators NEREUS PHARMACEUTICALS INC (US) 2009-11-25 EP disclosed